Mechanisms of opioid tolerance: Emerging evidence and therapeutic implications

Canadian Journal of Anesthesia

Volumn 54, Issue 12, 2007, Pages 969-976

  Joo, Daisy T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DELTA OPIATE RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; METHADONE; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; OPIATE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; RETINA S ANTIGEN; SUFENTANIL;

DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG TOLERANCE; EDITORIAL; ENZYME ACTIVITY; HUMAN; LOW DRUG DOSE; NEUROTRANSMISSION; PAIN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RECEPTOR UPREGULATION; SPINAL CORD DORSAL HORN;

EID: 38849117177     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03016630     Document Type: Editorial

References (24)

1. Gintzler AR, Chakrabarti S. Post-opioid receptor adaptations to chronic morphine: altered functionality and associations of signaling molecules. Life Sci 2006; 79: 717-22.
2. Grain SM, Shen KF. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000; 84: 121-31.
3. Liu JG, Anand KJ. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 2001; 38: 1-19.
4. Johnson EE, Christie MJ, Connor M. The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neurosignals 2005; 14: 290-302.
5. Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS. Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol Pharmacol 2004; 66: 106-12.
6. Groer CE, Tidgewell LC, Moyer RA, et al. An opioid agonist that does not induce micro-opioid receptor arrestin interactions or receptor internalization. Mol Pharmacol 2007; 71: 549-57.
7. Finn AK, Whistler JL. Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 2001; 32: 829-39.
8. Marie N, Aguila B, Allouche S. Tracking the opioid receptors on the way of desensitization. Cell Signal 2006; 18: 1815-33.
9. Keith DE, Murray SR, Zaki PA, et al. Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 1996; 271: 19021-4.
10. Zuo Z. The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance. Anesth Analg 2005; 101: 728-34.
11. Koch T, Widera A, Bartzsch K, et al. Receptor endocytosis counteracts the development of opioid tolerance. Mol Pharmacol 2005; 67: 280-7.
12. He L, Whistler JL. An opiate cocktail that reduces morphine tolerance and dependence. Curr Biol 2005; 15: 1028-33.
13. Trujillo KA. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl) 2000; 151: 121-41.
14. Ueda H. Locus-specific involvement of anti-opioid systems in morphine tolerance and dependence. Ann N Y Acad Sci 2004; 1025: 376-82.
15. Hsu MM, Wong CS. The roles of pain facilitatory systems in opioid tolerance. Acta Anaesthesiol Sin 2000; 38: 155-66.
16. Trang T, Quirion R, Jhamandas K. The spinal basis of opioid tolerance and physical dependence: involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites. Peptides 2005; 26: 1346-55.
17. Chen L, Huang LY. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 1991; 7: 319-26.
18. Chen L, Huang LY. Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992; 356: 521-3.
19. Zhao M, Joo DT. Subpopulation of dorsal horn neurons displays enhanced N-methyl-D-aspartate receptor function after chronic morphine exposure. Anesthesiology 2006; 104: 815-25.
20. Subramaniam LC, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004; 99: 482-95.
21. Zhang X, Bao L, Guan JS. Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 2006; 27: 324-9.
22. Alt A, Clark MJ, Woods JH, Traynor JR. Mu and delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells. Br J Pharmacol 2002; 135: 217-25.
23. Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, George SR. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem 2005; 280: 38478-88.
24. Milligan G. Opioid receptors and their interacting proteins. Neuromolecular Med 2005; 7: 51-9.